Selectivity arises when a capture or detection antibody recognizes the intended protein rather than unrelated molecules in the sample. This antibody-antigen interaction allows the assay to distinguish a target cytokine, chemokine, antibody, microbial protein, or other biomarker within serum, plasma, or culture medium. Greater target specificity makes the measured signal more directly interpretable as evidence of that protein’s presence.
In these assays, the colorimetric, fluorescent, or luminescent signal is designed to vary with the amount of target protein present. A stronger signal therefore indicates a higher measured concentration under the assay conditions, while a weaker signal indicates less target. This relationship enables comparisons among biological samples and supports quantitative assessment of immune or infection-associated changes.
Colorimetric, fluorescent, and luminescent readouts provide alternative ways to convert antibody-antigen recognition into measurable data. The essential principle remains the same: target recognition produces a signal whose magnitude relates to protein concentration. Selecting among these formats allows investigators to match the detection approach to the assay design and the type of quantitative comparison required across samples.
The identity of the measured protein determines which biological process the result may illuminate. Cytokines and chemokines can report immune communication, antibodies can reflect immune responses, and microbial proteins can provide information about pathogen-related activity. Measuring these distinct target classes helps connect extracellular protein changes with cell signaling, pathogen-host interactions, treatment responses, or disease progression.
Common sample types include serum, plasma, and cell culture supernatants. Serum and plasma provide information from biological fluids, whereas culture supernatants allow analysis of proteins released by cells under experimental conditions. Choosing between them depends on whether the study aims to examine systemic disease-related changes or protein release from cells in a controlled research model.
A typical workflow identifies the target protein, applies a capture or detection antibody that recognizes it, and measures the resulting colorimetric, fluorescent, or luminescent signal. The signal is then related to the target’s concentration in the tested sample. This workflow can be applied to serum, plasma, or culture supernatants to compare extracellular protein levels across experimental conditions.
They are useful when investigators need to characterize immune activation, pathogen-host interactions, treatment responses, or disease progression through released proteins. For example, measuring cytokines, chemokines, antibodies, or microbial proteins can reveal changes in immune signaling or infection-associated biology. Results from these assays provide molecular measurements that complement broader observations of cellular or disease responses.